Cargando…
The Emerging Role of Ofatumumab in the Treatment of Chronic Lymphocytic Leukemia
The treatment of chronic lymphocytic leukemia (CLL) has evolved over the past decade. Our better understanding of disease biology and risk stratification has allowed delivering more effective therapies. In fact, front-line chemoimmunotherapy has demonstrated improvement in overall survival when comp...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076040/ https://www.ncbi.nlm.nih.gov/pubmed/21499555 http://dx.doi.org/10.4137/CMO.S4087 |